Merck Loses Injunction Bid In Generic Diabetes Drug Suit
By Ryan Davis ( April 5, 2013, 6:26 PM EDT) -- An Indian court on Friday rejected Merck Sharp & Dohme Corp.'s request for a preliminary injunction in its patent suit over Glenmark Pharmaceuticals Ltd.'s generic version of Merck's diabetes drugs Januvia and Janumet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.